Dr. Martin-Immanuel Bittner is the CEO of Arctoris, the world's first fully automated drug discovery platform that he co-founded in Oxford in 2016. His goal is to change the way we approach drug discovery - moving towards a truly data-driven model, with the right data at the right time empowering us to make the right decisions, accelerating the path towards the clinic. He partners with biotech and pharma companies globally, delivering integrated drug discovery projects from idea to IND, enabled by a team of expert scientists and their unique technology platform.
Unlocking Hyper-Personalized Learning in Medicine! Join us for an insightful chat with Dr. Sievert Weiss, co-founder of AMBOSS. Discover how digital tools create tailored...
What is the difference between venture capital, private equity, and growth equity? What is the value of resilience and grit? And when exactly do...
How do investment banking and financial advisory play a role in facilitating thetransformation and innovation in the healthcare ecosystem? Can you develop a business...